Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-guided pazopanib dosing
NL-OMON28938Not yet recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of pazopanib, sponsored by Netherlands Cancer Institute. Planned start Aug 2013; status: not yet recruiting.
02
Drugs
pazopanib
Beyond the preview
Go deeper on NL-OMON28938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28938.